clinical research center of nevada

Clinical Research Center

Clinical research expertise and resources for clinical, translational and biomedical researchers

Elevate your Research

The CRC is a centralized 5470-square foot research space located in the Center for Molecular Medicine, CMM 230. The CRC is a fully outfitted clinic space which includes eleven private outpatient rooms for research clinic visits, two blood draw stations, and physician consultation areas. Dedicated space provides for IP storage and preparation, as well as sample processing and storage, including countertop refrigerated centrifuge, 30°, -20°, and -80° C refrigerators and freezers.

• Eleven clinical examination rooms equipped with exam table, otoscope, ophthalmoscope, vital signs equipment, and sink
• Basic specimen processing area equipped with refrigerated centrifuge
• Ambient, cold, and frozen secure storage for investigational product or short term specimen storage, monitored and recorded per SOP, that includes two 2-8° C refrigerators, a -20° C freezer, and a -80° C freezer
• Access to ice and dry ice in contiguous lab space
• Automated vital signs monitor, AED, limited anthropometric equipment, secure document disposal, printer/fax/copier/scanner, analog line for data transmission
• Calibration and service record maintenance for all CRC equipment
• CRC Standard Operating Procedures (SOP) Manual

Work with a Team of Experts

The operational team includes a part time research pharmacist, a part time emergency medicine specialist, research director, center manager and study coordinators.

The Director of Research and Clinical Research Administrative Manager provide consultation and analysis of project design, logistics and resource needs. The manager will also work closely with researchers and medical trainees to find suitable matches that synergize research objectives and expose students to unique and broad research opportunities. The manager also supports researchers with research budget preparation and cost management, regulatory compliance, IRB navigation and human research protection training requirements.

• Mission & What Defines Us
• Privacy Policy

M3-Wake Research Acquires Clinical Research Center of Nevada

Renowned research network expands operations into nevada, adding expertise in vaccines, sleep disorders, and pediatric research.

[RALEIGH, NC] – M3 Wake Research Associates, announces the acquisition of Clinical Research Center of Nevada (CRCN), one of the largest clinical research organizations in Nevada, and a leading provider of quality and comprehensive multispecialty clinical research services. This acquisition expands Wake Research’s coast-to-coast coverage of clinical research populations in the United States and encompasses communities of nearly 21 million people.

“This exciting acquisition brings one of the most experienced and recognized sites in the industry into our nationwide network,” stated Ella Grach, MD, President and Chief Executive Officer of Wake Research. “Darlene Steljes and the CRCN team have built a strong, successful operation offering advanced expertise in many specialties with extensive attention to vaccines, sleep disorders, and pediatric research,” she added.

“With its reputation for being patient-focused, and as the ‘go-to site’ for many indications, CRCN will be a key part of our continued research network expansion,” Dr. Grach continued. “Combining forces with CRCN will enable us to provide even greater opportunities for our patients’ health. Together, we will continue meeting the evolving needs of the drug discovery process and closing the gap between clinical research and healthcare by offering clinical trials as a care option.”

M3-Wake Research was originally founded by a large multi-specialty group practice and has conducted clinical research studies since 1989. Today, it is among the largest Phase I-IV clinical trial site service companies in North America. From its corporate office based in the Research Triangle Park area of Raleigh, NC, M3-Wake Research has built a combined database of more than 950,000 subjects to date, with an integrated network of 16 research sites operating in seven states: Alabama, Arizona, California, Georgia, North Carolina, Tennessee, and Texas. Their board-certified physicians have completed more than 7,100 successful clinical trials in most major therapeutic areas, with particular expertise in gastroenterology, neuroscience, dermatology, endocrinology, immunology, and women’s health.

“Along with co-owner Troy Odynski, and the entire CRCN team, I look forward to our future growth as part of M3 Wake Research and their national network of clinical research operations,” states Darlene Steljes, CEO and co-owner of CRCN. “Our patients, providers, and sponsors will benefit immensely from the wealth of additional resources provided by M3-Wake Research.”

Since 1996, CRCN has successfully connected board-certified investigators with clinical trials across a broad range of therapeutic areas. The integration of CRCN into the national network of M3-Wake Research adds six investigator sites and more than 100,000 potential subjects, and enables the existing CRCN network to benefit from M3 Wake’s industry-leading infrastructure including centralized patient recruitment and retention, a company-wide QA/QC program, an in-house training program, and marketing and advertising services. M3 Wake Research builds upon the success of a fully integrated and dedicated research site model. Further, by leveraging centralized marketing and advertising services, a call center, accelerated patient engagement program, and the individual successes of each site, efficiencies have increased exponentially, as recognized by many sponsors already.

With this acquisition, CRCN joins the family of M3 USA brands including: MDLinx, a clinical education and medical news website; The Medicus Firm, a physician and advanced practitioner recruiting firm; and PracticeMatch, which provides healthcare employers with the nation’s largest physician recruitment marketing resource. No further financial details of the transaction were made publicly available at this time.

About M3 Inc.:

M3 Inc. operates in the US, Asia, and Europe with over 4 million physician members globally via its physician websites such as mdlinx.com, m3.com, research.m3.com, doctors.net.uk, medigate.net and medlive.cn. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (TYO:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Inc. provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, Beijing, and Seoul.

About M3-Wake Research, Inc.:

M3-Wake Research is an organization of integrated investigational sites, committed to excellence, working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device and pharmaceutical industries. M3-Wake Research’s 16 sites are fully equipped to meet the needs of sponsors and CROs in the conduct of Phase I-IV clinical trials in a large variety of indications.

M3-Wake Research is known for effectively combining strategic volunteer recruitment, rapid trial start-up and subject enrollment/retention with high-quality clinical trial conduct using standardized operating procedures and centralized marketing and advertising. M3-Wake Research sites have conducted more than 7,000 research studies for hundreds of pharmaceutical and biotech sponsors and CROs. Wake Research’s mission is to bring novel medications, biologics and devices through clinical research to as many people as possible while providing unparalleled service and exceptional value to clinical trial partners and stakeholders.

• Patient Login
• Partner Login
• Become A Member
• Search Clinical Trials
• About Clinical Trials
• Virtual Clinical Trials

Latest Blog Posts

Services for research sites.

• Study Listings
• Clinical Ad Network™
• Patient Direct Mail Alerts
• Create Partner Account

National Recruitment Services

• Multicenter Study Listings
• Digital Marketing Strategies
• Site Identification Services
• Direct to Patient Advertising

News And Information

• Case Studies
• Patient Recruitment Insider Blog
• For Research Sites
• Study Screening Websites

Research Site Profile

• Clinic Profile List

Clinical Research Center of Nevada - Wake

2020 Wellness Way Suite 206 Las Vegas, NV 89106

Research Site Introduction:

Clinical Research Center of Nevada (CRCN) is one of the largest clinical research organizations in Nevada, and a leading provider of quality and comprehensive multispecialty clinical research services.

Research Site Description:

Therapeutic areas and experience.

CRCN offers advanced expertise in many specialties with extensive attention to vaccines, sleep disorders, and pediatric research.

When Sponsors or CRO’s contact us about a potential study, they are often surprised by the wide range of therapeutic areas that we have a Principal Investigator and the patient population to support. We can offer this level of service because each of our Principal Investigators contribute their own specialties, interests and patient populations to our existing experience.

Our primary therapeutic areas include:

• Sleep Disorders
• Internal Medicine
• Pulmonology
• Opthalmology
• Pain Management
• Womens Medicine
• Hypertension
• Gastroenterology
• Dermatology

View our currently enrolling studies here .

All sites have well equipped examination rooms, controlled access storage and equipment as required for each study.

Additional Information:

CRCN is a part of Wake Research, an integrated organization of premier investigational sites working closely with and meeting the needs of the biopharmaceutical, biotechnology, medical device, pharmaceutical industry and clinical research organizations in North America. Wake Research is affiliated with large multi-specialty group practices, hospitals and healthcare systems. Additionally, Wake Research has its own proprietary patient database of more than 2 million potential clinical trial participants—men and women, children and adults, across all ethnicities—for all kinds of adaptive and other types of trial designs.

Contact Information:

Study Hotline (702) 893-8968

Main Office: Clinical Research Center of Nevada 1012 East Sahara Ave. Las Vegas, NV 89104

Mon-Thurs: 8am-5pm Fri: 8am-4:30pm

https://www.crcnevada.com/

Active Studies:

• Type 2 Diabetes - Las Vegas NV
• Vulvovaginal Management - Las Vegas NV
• Severe Hypertriglyceridemia - Las Vegas NV
• Early Alzheimer's Disease - Las Vegas NV
• Asthma - Las Vegas NV

© 1998-2024 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides information on clinical trials and other research opportunities worldwide.

ClinicalConnection.com does not conduct or endorse this research. Please consult your physician before participating.

• Exploring the Microbiome: Gut Health, Probiotics and Clinical Trials
• Nutrition and Clinical Trials: Latest Clinical Research on Diet's Role in Disease
• Personalized Medicine: The Power of Genetics in Clinical Trials
• Depression Clinical Trials Near Me: Current Research and How to Participate

Useful Links

1998-2024 © All Rights Reserved. Privacy Policy | Terms of Service

• Entertainment
• Investigations
• Latest Headlines
• What Are They Hiding?
• 2024 Election
• Clark County
• Nation and World
• Science and Technology
• Road Warrior
• Las Vegas Weather
• East Valley
• North Las Vegas
• Summerlin/Centennial Hills
• Remembering Oct. 1, 2017
• Deborah Wall
• Natalie Burt
• Remembering Jeff German
• Police Accountability
• Alpine Fire
• 100 Years of Growth
• Dangerous Driving
• Raiders News
• Golden Knights
• UNLV Football
• UNLV Basketball
• Nevada Preps
• Sports Betting 101
• Las Vegas Sportsbooks
• National Finals Rodeo
• Where Are They Now?
• On TV/Radio
• MMA and UFC
• Casinos & Gaming
• Conventions
• Inside Gaming
• Entrepreneurs
• Real Estate News
• Business Press
• Sheldon Adelson (1933-2021)
• Debra J. Saunders
• Michael Ramirez cartoons
• Victor Joecks
• Richard A. Epstein
• Victor Davis Hanson
• Drawing Board
• Homicide Tracker
• Faces of Death Row
• Kats’ Cool Hangs
• Arts & Culture
• Home and Garden
• Las Vegas Hiking Guide
• RJ Magazine
• Today’s Obituaries
• Submit an obit
• Dealer News
• Classifieds
• Place a Classified Ad
• Provided Content
• Real Estate Millions
• Internships
• Service Directory
• Transportation
• Merchandise
• Legal Information
• Real Estate Classifieds
• Garage Sales
• Contests and Promotions
• Best of Las Vegas
• Nevada State Bank
• Verizon Business
• P3 Health Partners
• Adult Health
• Star Nursery
• Partner Articles
• Ignite Funding
• Supplements
• Travel Nevada
• Subscriptions
• Newsletters
• Advertise with Us

• >> Life
• >> Health

Volunteers needed for COVID-19 vaccine trial in Las Vegas

Wake Research-Clinical Research Center of Nevada is moving forward in attempts to find a COVID-19 vaccine.

Dr. Michael Levin, investigator for the Phase 3 trial of the first COVID-19 vaccine developed in the U.S. by the National Institute of Health and Moderna Inc., talks about what health experts hope to learn from the trial.

Wake is looking for volunteers 18 years of age and older, with and without health issues for clinical trials. They will be compensated for their time and travel.

The goal of wastewater surveillance effort is to determine if any new strain of the constantly evolving disease might pose a problem for humans and the community.

A proposal asked Boyd Gaming shareholders to study the effects of making casinos smoke-free. It was the first of three proposals across the industry to get a vote.

For some people, the day of flowers and hugs and tributes to Mom can spark sadness, stress or even resentment.

We’d all love to find an effortless way to lose weight. Most of these products work because they come with a low-calorie plan. And they encourage exercise.

It takes years to muster the courage to live authentically and understand what truly makes us happy. That’s what the Long-Life Era is all about.

Research shows that smartphones are particularly disruptive to the circadian clock that regulates sleep and other hormones.

Sharp-eyed grocery shoppers may notice new labels in the dairy aisle touting yogurt as way to reduce the risk of Type 2 diabetes.

As the acclaimed series returns for Season 3, Jean Smart is grateful for the love and laughter that “Hacks” has brought her way.

Finding and researching doctors is a lot easier than it used to be. Today, there are variety of websites you can turn to.

Dear Toni: My concern is that my parents cannot properly take care of themselves and that something serious could happen to them living on their own.

Enrolling Studies at Clinical Research Center of Nevada

Early alzheimer’s disease - clinical research center of nevada.

A research study testing the safety and effectiveness of a new treatment for individuals with Early Alzheimer's.

RSV Treatment - Clinical Research Center of Nevada

A clinical research study for a potential treatment for RSV in those 18-64 years of age.

Severe Asthma - Clinical Research Center of Nevada

A clinical research study evaluating a drug for adults with severe asthma.

Severe Hypertriglyceridemia - Clinical Research Center of Nevada

A clinical study for individuals with severe hypertriglyceridemia

Tardive Dyskinesia - Clinical Research Center of Nevada

An observational study of adults with Tardive Dyskinesia.

Type 2 Diabetes - Clinical Research Center of Nevada

A clinical research study for individuals with Type 2 Diabetes.

Upper Limb Spasticity - Clinical Research Center of Nevada

A clinical research study for individuals with upper limb spasticity.

Vaginal Atrophy /Vaginal Dryness Study - Clinical Research Center of Nevada

A clinical study testing the safety and effectiveness of a steroidal gel for vaginal atrophy.

Volunteer - Clinical Research Center of Nevada

Make a difference by participating in a clinical research study.

Office of Clinical Trials

• Office of Research Integrity
• Office of Sponsored Programs
• Office of Undergraduate Research
• International Gaming Institute
• Nevada Institute of Personalized Medicine
• National Supercomputing Institute
• Science and Engineering Building
• Harry Reid Center
• Policies & Forms
• Faculty Awards
• Councils & Committees
• Faculty/Staff Directory
• Directories

Quick Links

• Directories Home
• Colleges, Schools, and Departments
• Administrative Units
• Research Centers and Institutes
• Resources and Services
• Employee Directory
• Contact UNLV
• Social Media Directory
• UNLV Mobile Apps
• Research Home
• Division Units

The UNLV Office of Clinical Trials is a vital resource in supporting interventional, observational, and epidemiological research in relation to human subjects. Our office assists with review, analysis, preparation, and execution of:

• Industry-sponsored
• Investigator-initiated clinical research
• Federally funded clinical research (with OSP)

The office also supports:

• Study feasibility
• Policies and procedures
• Logistical considerations
• Central data management
• Budgetary review and negotiation, financial management
• Contractual obligations

Affiliated Research Service Sites

In support of cross-collaboration and maintaining the feasibility of research studies, Office of Clinical Trials has established partnerships within the community that support the research and assessments necessary to meet protocol requirements.

• UNLV Investigational Drug Services (IDS) Pharmacy
• University Medical Center of Southern Nevada
• Sunrise Hospital and Medical Center
• Desert Radiology
• Quest Diagnostics
• Exam One (a Quest Diagnostic Company)
• CPL Laboratories
• LMC Pathology

School of Medicine Resources

The Kirk Kerkorian School of Medicine at UNLV has experienced clinical research coordinators that liaise with industry sponsors and provide the following service support to researchers:

• Preparation and submission of materials for internal committee reviews and initial, continuing, and amendment preparations for the internal review board (IRB).
• Site selection/qualification visits and site initiation visits.
• Protocol review and training.
• Meeting with, preparing with, and analyzing between collaborating departments/service sites.
• Investigator meetings, source documentation development, electronic data capture training, and updating the university’s clinical trials management system.
• Assisting study data monitors for site visits, audits, and subject data review.

Master Confidentiality Disclosure Agreements

To help expedite the review of protocols for interested potential investigators, the Office of Clinical Trials is currently working with sponsors/CROs to finalize general or master Confidentiality Disclosure Agreements.

• Abbvie Pharmaceuticals
• Gilead Sciences
• Medspace Corporation
• Novo Nordisk
• Exact Science

Protocol Activation Process

• Investigator Identifies a Protocol
• A CDA is sent to the Clinical Trials Office at UNLV
• A Sponsor Feasibility Questionnaire is sent to the Investigator
• Protocol reviewed for feasibility by departments supporting schedule of assessments
• Budgets and Contracts
• Informed Consent Form(s) drafted
• Submit SMFRC approval letter, Initial IRB Application Packet to ORI and IRB of Record
• IRB review and Approval
• Protocol Training/Site Initiation Visit

Investigator Initiated Protocol Assistance/Support

Office of Clinical Trials is HAPPY to help with any of the following:

• IND/IDE Application
• Subject Population
• Schedule of Assessments required
• Protocol Templates based on funding source, phase, intervention, IND/IDE application, subject population, specifications and requirements of sponsor.
• Funding Source
• Industry – will work with Sponsors to obtain proper funding and contracts.
• Grants – will work with OSP to verify protocol meets all requirements.

Michelle Tomasino Manager, UNLV Office of Clinical Trials 702-895-4923 [email protected] [email protected]

Availability

Tuesdays UNLV Clinic (1707 Building) 2 nd Floor Conference Room Call to schedule a time.

Find a Trial

Use our guide to learn which trials are right for you.

Select your condition

Common conditions.

• Atrial Fibrillation
• Breast Cancer
• Constipation
• Dermatology
• Fibromyalgia
• Healthy Studies
• High Blood Pressure (Hypertension)
• High Cholesterol
• Irritable Bowel Syndrome (IBS)
• Migraine Headaches
• Obesity Weight Loss
• Osteoarthritis (OA)
• Renal Impairment / Chronic Kidney Disease
• Skin Cancer
• Smoking Cessation

All Conditions

• Alzheimer Disease
• Athletes Foot
• Benign Prostate Hyperplasia
• Bipolar Disorder
• Bladder Cancer
• Blood Cancer
• Brain Cancer
• Cervical Cancer
• Chronic Obstructive Pulmonary Disease
• Chronic Pain
• Cognitive Studies
• Colorectal Cancer
• Contraception
• Contraception Birth Control
• Contraception Birth Control Patch
• Crohns Disease
• Diabetic Neuropathy
• Digestive Disease
• Diverticulitis
• Eating Disorder
• Endometrial Cancer
• Endometriosis
• Erectile Dysfunction
• Flu (Influenza)
• Food Studies
• Gastroesophageal Reflux Disease
• Gastrointestinal
• Genital Herpes
• Hemorrhoids
• Hepatitis C
• Infectious Disease
• Infertility
• Influenza Vaccine
• Insomnia Sleep Studies
• Iron Deficiency Anemia
• Kidney Cancer
• Liver Cancer
• Low Back Pain/Arthritis Pain
• Lung Cancer
• Major Depression Disorder (MDD)
• Menses Disorders
• Multiple Sclerosis
• Osteoporosis
• Other Indications
• Ovarian Cancer
• Overactive Bladder
• Pancreatic Cancer
• Parkinsons Disease
• Peripheral Vascular Disease
• Polycythemia Vera
• Post-Surgical Pain
• Postherpatic Neuralgia
• Postmenopausal Syndrome
• Premature Ejaculation
• Prostate Cancer
• Psychiatric
• Restless Leg Syndrome
• Rheumatoid Arthritis
• Rheumatology
• Schizophrenia
• Shingles Vaccine
• Skin and Soft Tissue Infections
• Thyroid Cancer
• Tobacco Consumers
• Tobacco Consumers: SNUS, Chew, Dip
• Urinary Tract Infections
• Women's Studies

• Español
• Employees & Providers
• Renown Health
• University of Nevada, Reno
• Clinical Trial

Newly Expanded Clinical Research Center at UNR Med Fosters Collaboration and Research with Renown Health

• Tweet Tweet

October 05, 2022

Renown Health and the University of Nevada, Reno School of Medicine (UNR Med) are proud to announce a newly integrated and expanded research space called the Clinical Research Center (CRC). This space offers a dynamic physical location on the University of Nevada, Reno campus that supports the UNR Med and Renown Health research enterprise. "The partnership between Renown Health and UNR Med truly knows no bounds, and this Clinical Research Center is an incredible example of that endless possibility,” said Thomas Graf, MD, interim CEO of Renown Health.  “This new space will only continue to expand our community’s access to clinical research as part of patient care while providing the necessary resources to engage our students and support a healthy Nevada.”

This space’s capabilities include experienced staff with knowledge and skills in operationalizing FDA and non-FDA regulated clinical and translational research studies in a centralized 5,470-square foot research clinic housed in the Center for Molecular Medicine (CMM) at the University. This CRC space provides resources including:

• A centralized location next to the laboratory space that allows for strategic interdisciplinary collaboration between clinicians and basic scientists.
• Eleven private outpatient rooms for research clinic visits.
• Two blood draw stations.
• Physician consultation areas.
• Conference room for trial monitoring and consulting.
• Secure Investigational Product storage and preparation.
• Sample processing and storage, including countertop refrigerated centrifuges, 4°, -20° and -80° C refrigerators and freezers.

Operations around clinical research are becoming more complex so growing clinical research in our community will require expertise and dedicated space where clinical research can be conducted in a learning environment first,” said Danielle Eaton, Director of Clinical Research with UNR Med and Renown Health. “This Clinical Research Center provides such space and experienced staff where these research studies can be successfully completed. The CRC provides a training environment for students, residents, faculty and clinical research professional work-force that will be needed to bring cutting edge diagnostics, therapeutics and preventatives to our community.”

Meet the Team:

• Danielle Eaton, UNR Med Director of Clinical Research
• Kristen Gurnea, Renown Health Manager of Clinical Research
• Amber Emerson, UNR Med Project Manager
• Valerie Smith, UNR Med Center Administrative Manager
• Annie Beach-Hills, Gina Castro, Michelle Mejia and Amil Trujillo-King, UNR Med Study Coordinators
• Dr. John Westhoff, UNR Med Chair of Internal Medicine, Emergency Medicine physician
• Dr. Sean Kandel, UNR Med Associate Program Director for Resident Research, Associate Professor of Internal Medicine
• Dr. Amneet Rai, UNR Med Clinical research pharmacist
• Dr. Kellie Watkins, UNR Med Clinical Epidemiologist/Data Manager/Statistician

As part of the affiliation between UNR Med and Renown Health, the Clinical Research Office is part of an integrated Office of Clinical Research, which allows both entities to collaborate on shared research program objectives. This effort allows colleagues to partner on clinical research, and to leverage bench-to-bedside research and delivery of leading-edge healthcare to northern Nevadans.

About Renown Health

Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.

About UNR Med  

The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.

• Previous Article

Renown's Dr. Kate Ward Honored with Nevada Society of Health System Pharmacists (NVSHP) President's Award

• Next Article

Medicare’s Annual Election Period Begins Oct. 15

Media contacts.

M: 775-287-6788  

E: [email protected]

Renown Public Relations

M: 775-691-7308

E: [email protected]  

Digital Assets

Renown Health logos, product screenshots, photos, and other digital assets.

Related News

Renown health and aetna® announce contract agreement.

• Awards and Accreditations

Reno Home to Top-Performing Supply Chain of Distinction

Renown south meadows medical center earns highest "a" hospital safety grade from the leapfrog group, renown health news.

Transactions

Clinical research center of nevada acquired by m3, inc..

Client: Clinical Research Center of Nevada is a Phase I-IV clinical research site

Role: Edgemont Partners acted as exclusive financial advisor to Clinical Research Center of Nevada in its sale to M3, Inc.

Location: Las Vegas, NV

Sector: Pharmaceutical Services

Lead Banker: David Blume

acquired by

Supporting Cancer Research in Our Community

Nevada  •   Arizona  •   California  •  Washington

Find a Clinical Trial

• View Affiliated Clinics

Nevada NCORP is a non-profit dedicated to promoting state-of-the-art cancer treatment for patients in our community. We bring clinical trials to participating clinics and hospitals to advance new treatment, screening, and prevention options.

We support cancer research in four western states and new clinical trials are updated daily. Search the trials for openings based on cancer type, age, location and more.

Affiliated Hospitals and Clinics

We work with more than 50 hospitals and clinics in Nevada, Washington, Arizona and California to bring cancer research to our communities. Find local participants near you.

View Affiliates

The Nevada NCORP makes it possible for affiliated community oncology clinics to offer NCI funded cancer research studies to their patients. Our goal is to give patients access to investigational therapies without having to leave the community.

Coordinate local research studies

We support dedicated research coordinators in affiliated community hospitals and clinics and provide data management and regulatory requirements of conducting research minimizing the impact of research on busy clinic physicians and nurses.

Support Researchers

We arrange for patient data to connect with national research labs and biobanks and provide timely information to the national trial teams for analysis. Our affiliated physicians review and comply with all study requirements to ensure that patient data can be used to advance studies.

Educate Patients & Doctors

We provide research study participants and their physicians with updates as they are released, distribute informational materials to hospitals and clinics, and connect patients and physicians with available research for cancer, symptom management, cancer prevention and cancer screening.

Distribute Funding

We track funded clinical research study activities through the National Clinical Trials Network and distribute funding as directed by the study sponsor to select clinics and hospitals in Nevada, Arizona, California and Washington.

Frequently Asked Questions

How do i find a cancer doctor.

Your primary care doctor or insurance company will help you to choose a cancer doctor, also called an oncologist. The Nevada NCORP does not employ doctors, we work with oncologists who are at clinics and hospitals in the community.

I already have a doctor, can they join the Nevada NCORP?

The Nevada NCORP is accepting new physicians.  If you doctor is interested in joining us there is information on our Affiliated Hospitals and Clinics page .

What are clinical trials?

Clinical trials are research studies that involve people.  Clinical trials are the way that doctors find ways to improve treatments and quality of life for people who have or may develop certain diseases.

What are the types of cancer clinical trials?

Treatment trials test new drugs or new ways to use current drugs, vaccines, perform surgery, or deliver radiation therapy to improve the effectiveness of cancer treatment.

Symptom Management trials to find better ways to manage the effects of cancer or the side effects of cancer treatments.

Prevention trials test a new treatment or lifestyle change that may lower the risk of getting a specific cancer.

Screening trials test a new or different way of detecting cancer.

Tissue collection trials test new ways of identifying cancer characteristics to make treatments more effective or personalized.

How safe are clinical trials?

The ethical and legal principles for medical practice also apply to clinical trials. Also, National Cancer Institute (NCI) approved clinical research is federally regulated with many required protections for participants.

Every clinical trial in the U.S. must be approved and monitored by an Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits.

An IRB can stop a clinical trial if it appears to be causing unexpected harm to the patients.

For more information please visit:

https://www.cancer.gov/about-cancer/treatment/clinical-trials/patient-safety

What is the cost of participation?

Costs of care may be covered by private or public insurance companies or in some cases a clinical trial sponsor. Before joining a clinical trial it is important to discuss the costs with your healthcare provider. The consent form with provide information about costs before joining a clinical trial.

How do I join a clinical trial?

Every clinical trial has an action plan called a protocol, that describes what will be done in the trial and why each part of the trial is needed. Each protocol includes guidelines called eligibility criteria. The eligibility criteria explain who can and cannot participate.

Eligibility criteria has many factors which may include age, sex, medical history, and current health status. For cancer treatment trials eligibility may include the type and stage of cancer, and the type(s) of cancer treatment already received. Your doctor will make sure the study is right for you before you begin.

Will I get a placebo?

A placebo is an inactive pill, liquid, powder or injection that has no treatment value.

If a placebo is used by itself, it is because no standard treatment exists. In such a case, a trial would compare a new treatment to a placebo.

Mostly placebos are given along with a standard treatment. Example: a trial may compare a standard drug plus a new drug to the effects of the same standard drug plus a placebo.

When you consent join a study the treatments will be explained to you in detail, you should understand the treatment possibilities before you agree to join the study.

Subscribe for More Information

Nevada NCORP is a non-profit dedicated to promoting state-of-the-art cancer treatment for patients in Nevada, Arizona, California and Washington. We bring clinical trials to participating clinics and hospitals to advance new treatment, screening, and prevention options.

© 2024 Nevada NCORP. All Rights Reserved.

Privacy Policy   |  Terms of Use   |  Commitment to Accessibility

• Clinical Trials
• Hospitals & Clinics

ADVANCING MEDICINE SAVING LIVES

Dedication for sponsors and cros.

Las Vegas Clinical Trials is a dedicated research site coupled with multi-specialty and family practice doctors that conducts Phase I-IV research studies. We are committed to providing our Sponsors and CROs with the highest quality of data while meeting or exceeding our enrollment goals!

“ Our success is contributed to having a well-educated and diverse corporate team that is able to keep its finger on the pulse at all times, unlike a SMO we are a hands-on organization that knows how to achieve high enrollment while providing high quality data."

David S. Wilson, Founder and CEO

CURRENTLY ENROLLING PARTICIPANTS FOR OUR HIV RESEARCH STUDY →

CLINICAL RESEARCH SERVICES

Our mission.

WHY PARTICIPATE IN CLINICAL TRIALS?

Play a critical role in the development of innovative future treatments and potential cures.

Gain access to thorough health evaluations and oversight from medical experts.

Be compensated as a recognition for your time and contribution to medical progress.

Clinical Trial Assessment

Frequently Asked Questions

Blog and insights.

Discovering Medicine

Understanding Clinical Trials

Medical Writing in Healthcare

Have questions.

• Get Directions
• (702) 570-6107
• Schedule Appointment

Make Your Life and Health a Priority

CROSN practice features quality primary care and groundbreaking research.

WELCOME TO CROSN

Internal medicine las vegas nevada.

Internal Medicine Las Vegas Nevada offers primary care and advanced research solutions for patients of all ages. CROSN’s highly trained and experienced team is committed to providing generalized medicine services, like diabetes management, high blood pressure treatment, and physical exams, including physical exams for immigrants. We also conduct groundbreaking research efforts to relieve migraines, treat high cholesterol, study the efficacy of colorectal cancer screenings, and more. We also deliver intravenous infusion therapies to help you replenish fluids and rejuvenate your health. We welcome you to contact us in Las Vegas, NV, and schedule a consultation to make your life and wellness a priority. Our staff speaks English and Spanish. We also serve the Clark County area.

Primary Care

Our healthcare providers will optimize your health and wellness with evidence-based treatments to help you live your best possible life.

IV Infusion Therapy

Vitamin therapy boosts immunity and energy levels, leaving patients feeling revitalized and rejuvenated after an intravenous infusion of nutrients.

Clinical Research

We explore the safety & effectiveness of medications, diagnostic products, & treatment regimens used to diagnose, treat, or prevent disease.

All Services

We specialize in generalized medicine services, vitamin infusion therapies, and clinical research programs that will help boost health and wellness.

• Dr. Roger Estevez

Board certified in internal medicine, Dr. Roger Estevez is the medical director of Internal Medicine Las Vegas Nevada. He spends ample time with patients to get to know their concerns, conduct an examination, and thoroughly discuss treatment options and possible research participation if they are interested. Dr. Estevez works in partnership with our patients to provide primary patient care that tends to their needs and goals for better health and wellness.

Our experienced family of specialists is passionate about making your health and wellness a priority. Our professionals at Internal Medicine Las Vegas Nevada are highly skilled in providing primary care and advanced clinical trials to men and women in Las Vegas, NV and the surrounding area. We provide personalized care and guide you on your path to wellness with highly effective and safe treatments that may lead to a healthier lifestyle and bring you symptom relief.

We'd Love to Hear from You!

• 4020 Pecos-McLeod Interconnect Las Vegas, NV 89121

Actual outcomes may differ, and individual results are not assured. Variations may occur among individuals. Images may feature models.

Internal Medicine Las Vegas Nevada is a comprehensive medical center that provides primary care and advanced research services to patients in Las Vegas, NV.

Quick Links

Contact info.

• [email protected]

Copyright © 2023 Internal Medicine Las Vegas Nevada

Visit Comprehensive Cancer

Request an Appointment or Refer a Patient Online.

Appointments for Current Comprehensive Patients

Welcome to comprehensive cancer centers.

Comprehensive, an affiliate of The US Oncology Network, is an award-winning multispecialty practice comprising medical oncology, hematology, radiation oncology, breast surgery, pulmonary medicine, cancer genetic counseling and clinical research.

Meet Our Physicians

• Clinical Research

Treatment Centers

Mycare plus, comprehensive cancer services.

Our practice’s integrated range of disciplines and treatment services sets us apart.

When it comes to cancer treatment, blood disorders and the lungs, we know you have choices for different treatment options. With more doctors trusting their patients to Comprehensive Cancer Centers than to all other Nevada cancer treatment facilities combined, be assured that you have made the right one in Comprehensive.

MEDICAL ONCOLOGY

Comprehensive Cancer’s board-certified and award-winning medical oncologists provide patients with treatment in a supportive and caring environment.

Comprehensive offers cancer treatment options including therapies for serious blood disorders and blood cancers such as leukemia, lymphoma, and myeloma.

RADIATION ONCOLOGY

Our team uses advanced treatment planning systems and state-of-the-art radiation technology to deliver internal and external radiation.

BREAST SURGERY

Our team conducts non-cancer and cancer-related surgeries and provides current and effective treatment options for breast care and breast cancer patients

PULMONARY DISEASE

Comprehensive’s board certified pulmonologists are dedicated to diagnosing, treating and educating adult patients with lung diseases and sleep disorders

IMMUNOTHERAPY

Immunotherapy is treatment that uses your body’s own immune system to help fight cancer. The team at Comprehensive cancer uses the treatment to save lives.

CHEMOTHERAPY

Chemotherapy is part of a standardized regimen use to treat cancerous diseases with drugs that interfere with cancer cell growth and reproduction.

CYBERKNIFE®

CyberKnife® Radiosurgery offers patients with tumors a painless, non-invasive treatment alternative that requires no anesthesia and shorter recovery times.

CLINICAL RESEARCH

Comprehensive’s clinical research is an important step in finding new and better ways of treating cancer. The practice offers more than 170 Phase I, II & III trials annually.

DIAGNOSTIC IMAGING

Comprehensive’s state-of-the-art imaging services make access to scans convenient for patients, and ensures timely access to results for our physicians.

LABORATORY SERVICES

On-site laboratories provide quick results for laboratory tests, helping physicians prescribe or adjust treatment plans without any unnecessry delays.

Our pharmacists are trained in cancer treatment, with expertise to work with physicians and nurses to address complex therapies in an outpatient settings.

How Can Comprehensive Help?

Learn more about how the Comprehensive Cancer team helps patients with the following conditions.

• Bladder Cancer
• Brain Tumors
• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Ovarian Cancer
• Skin Cancer
• Pancreatic Cancer
• Prostate Cancer

Comprehensive Cancer’s Blog

Stay up-to-date with the latest ways to keep you healthy and inspired.

Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Search for terms

• Advanced Search
• See Studies by Topic
• See Studies on Map
• How to Search
• How to Use Search Results
• How to Find Results of Studies
• How to Read a Study Record

• Learn About Studies
• Other Sites About Studies
• Glossary of Common Site Terms

• Submit Studies to ClinicalTrials.gov PRS
• Why Should I Register and Submit Results?
• FDAAA 801 and the Final Rule
• How to Apply for a PRS Account
• How to Register Your Study
• How to Edit Your Study Record
• How to Submit Your Results
• Frequently Asked Questions
• Support Materials
• Training Materials

• Selected Publications
• Clinical Alerts and Advisories
• Trends, Charts, and Maps
• Downloading Content for Analysis

• ClinicalTrials.gov Background
• About the Results Database
• History, Policies, and Laws
• ClinicalTrials.gov Modernization
• Media/Press Resources
• Linking to This Site
• Terms and Conditions
• Search Results
• Study Record Detail

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age (RSVictory)

• Study Details
• Tabular View
• No Results Posted

The main purposes of Part A of this study are to evaluate the safety, tolerability, and immunogenicity of mRNA-1345 coadministered with a seasonal influenza vaccine (Afluria® Quadrivalent); to evaluate the impact of coadministered influenza vaccine on the immune response to RSV-A; and to evaluate the impact of coadministered RSV vaccine on the immune response to influenza.

The main purposes of Part B of this study are to evaluate the safety, tolerability, and immunogenicity of mRNA-1345 coadministered with mRNA-1273.214; to evaluate the effect of coadministered mRNA-1273.214 on the immune response to RSV-A; and to evaluate the effect of coadministered RSV vaccine on the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The main purposes of Part C (single arm, open-label) of this study are to evaluate the safety and tolerability of a booster dose (BD) of mRNA-1345 administered at 1 Year following a primary dose; to evaluate the immune response to RSV-A of a BD of mRNA 1345 administered at 1 Year following a primary dose; and to evaluate the immune response to RSV-B of a BD of mRNA-1345 administered at 1 Year following a primary dose.

Key Inclusion Criteria:

Parts A and B both:

• Adults ≥50 years of age on the day of the Randomization Visit (Day 1) who are primarily responsible for self-care and activities of daily living. Participants may have one or more chronic medical diagnoses, but should be medically stable as assessed by: Absence of changes in medical therapy within 1 month due to treatment failure or toxicity; Absence of medical events qualifying as SAEs within 1 month of the planned vaccination on Day 1; and absence of known, current, and life-limiting diagnoses which, in the opinion of the investigator, would make completion of the protocol unlikely.
• Able to comply with study requirements, including access to transportation for study visits.

Part B only:

• Fully vaccinated for COVID-19 with an approved primary series according to the locally authorized or approved regimen. If the most recent COVID-19 vaccine was part of a primary series, it must be ≥ 150 days before (or less per local guidance) Day 1. If the most recent COVID-19 vaccine was a booster dose, it must be ≥ 120 days before (or less per local guidance) Day 1.
• Participants at Part C study sites who have been enrolled in Part B (Groups 4 and 5) of this study; have immunogenicity blood sampling at Part B baseline and Day 29; completed the Day 211/end-of-study visits for Part B; were included in the per-protocol (PP) set; and received 1 dose of mRNA-1345 at least 12 months (but no later than 15 months) prior to the time of enrollment.

Key Exclusion Criteria:

• Participant has received or plans to receive any vaccine authorized or approved by a local health agency ≤28 days prior to study injections (Day 1) or plans to receive a vaccine authorized or approved by a local health agency within 28 days after the study injections.
• Prior participation in research involving receipt of any investigational product (drug/biologic/device including any investigational RSV product) within 45 days before the planned date of the Day 1 study injection.
• Participant has received a seasonal influenza vaccine or any other investigational influenza vaccine ≤180 days prior to the Randomization Visit (Day 1).
• History of a serious reaction to any prior vaccination, or Guillain-Barré syndrome within 6 weeks of any prior influenza immunization.
• Participated in an interventional clinical study within 28 days prior to the Screening Visit based on the medical history interview or plans to do so while participating in this study.
• Participant has received or plans to receive any vaccine authorized or approved by a local health agency ≤ 28 days prior to study injections (Day 1) or plans to receive a vaccine authorized or approved by a local health agency within 28 days after the study injections (with the exception of SARS-Cov-2 vaccination).
• Prior participation in research involving receipt of any investigational product (drug/biologic/device with the exception of RSV investigation products) within 45 days before the planned date of the Day 1 study injection.
• Prior receipt of any investigational/approved RSV product within 1 year of the Day 1 study injection.
• Has known history of SARS-CoV-2 infection within 90 days prior to enrollment.
• Participant had significant exposure to someone with SARS-CoV-2 infection or COVID-19 in the past 10 days, as defined by the United States (US) Centers for Disease Control and Prevention (CDC) as a close contact of someone who has had COVID-19.
• Participation in another interventional clinical research study where participant has received an investigational product (drug/biologic/device) within 6 months before the planned date of the BD Day 1 study injection. Any prior receipt of an investigational or approved vaccine against RSV, except as part of mRNA-1345 Study P302 Part B, is exclusionary.
• Participant has received or plans to receive any vaccine authorized or approved by a local health agency ≤28 days prior to the study injection (BD Day 1) or plans to receive a vaccine authorized or approved by a local health agency within 28 days after the study injections.
• History of a serious reaction to any prior vaccination or Guillain-Barré syndrome 6 weeks after any prior influenza immunization.

Other inclusion and/or exclusion criteria may apply.

• For Patients and Families
• For Researchers
• For Study Record Managers
• Customer Support
• Accessibility
• Viewers and Players
• Freedom of Information Act
• HHS Vulnerability Disclosure
• U.S. National Library of Medicine
• U.S. National Institutes of Health
• U.S. Department of Health and Human Services